Tumor Treating Fields Therapy

Tumor treating fields (TTF) therapy is a noninvasive technology intended to treat glioblastoma, malignant pleural mesothelioma, and non small cell lung cancer on an outpatient basis and at home using electrical fields. Glioblastoma multiforme (GBM) is the most common and deadly malignant brain tumor. It has a very poor prognosis and is associated with low quality of life during treatment. Malignant pleural mesothelioma is an aggressive tumor with few treatment options that is associated with significant morbidity and mortality. Non small cell cancer is the most common type of lung cancer (85%) encompassing 3 subtypes (adenocarcinoma, squamous cell, and large cell carcinoma) and prognosis depends on various factors, including the stage of the cancer, the type of treatment received, and the patient's overall health.